TipRanks
pc:eitph

EIT Pharma

A biotechnology company focused on developing therapies for infectious diseases. Its pipeline includes late-stage treatments such as lonafarnib for chronic hepatitis D.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$35M
Total Amount Raised$35M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$35M
Latest Funding Amount$35M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 31, 2026
Series A
$35.00M

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to EIT Pharma, helping you discover and navigate related company profiles.

Related News and Analysis